Bausch Health Cos., Inc.
(Toronto Stock Exchange : BHC)

( )
BHC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
MYOKMyoKardia, Inc. -0.03%221.941.8%$514.80m
HZNPHorizon Therapeutics Plc -1.47%78.465.8%$153.59m
VRXValeant Pharmaceuticals International, Inc. 0.58%17.2114.1%$101.27m
CTLTCatalent, Inc. -1.28%91.222.1%$87.19m
JAZZJazz Pharmaceuticals Plc -1.50%147.722.4%$85.89m
BHCBausch Health Cos., Inc. 0.58%17.210.0%$68.44m
ICLRICON plc 0.06%204.004.3%$49.79m
SAGESAGE Therapeutics, Inc. 0.91%69.728.6%$43.52m
ZGNXZogenix, Inc. -1.08%20.187.5%$42.59m
ARGXargenx SE -2.12%264.170.0%$42.31m
UTHRUnited Therapeutics Corp. 1.28%116.4714.1%$40.06m
AMRNAmarin Corp. Plc -2.33%5.031.5%$38.86m
ENDPEndo International Plc 13.25%5.648.7%$37.14m
SAVACassava Sciences, Inc. -6.11%9.840.0%$36.67m
PRGOPerrigo Co. Plc -3.69%45.636.8%$33.22m

Company Profile

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.